Atorvastatin 40mg
Atorvastatin 40mg is a pharmaceutical drug with 14 clinical trials. Currently 6 active trials ongoing. Historical success rate of 85.7%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
5
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.0%
6 of 8 finished
25.0%
2 ended early
6
trials recruiting
14
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Small Vessel Stroke
Prophylactic Treatment With Atorvastatin for Episodic Migraine.
ATORvastatin in Pulmonary TUBerculosis
Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig)
Effect of Ezetimibe on Gut Microbiota
Clinical Trials (14)
Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Small Vessel Stroke
Prophylactic Treatment With Atorvastatin for Episodic Migraine.
ATORvastatin in Pulmonary TUBerculosis
Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig)
Effect of Ezetimibe on Gut Microbiota
Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Comparison Between the Effects of High Doses Statin on Ventricular Remodeling in STEMI Patients
Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.
High-intensity Atorvastatin for Arteriovenous Fistula Failure (HAFF): A Feasibility Pilot Study
MUscle Side-Effects of Atorvastatin in Coronary Patients
A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and Dyslipidemia
COmparison and Modification in Neointimal Pattern Assessed by Optical Coherence Tomography With High Versus Moderate Efficacy Statin Treatment After Drug Eluting Stent Implantation: COMPASS Trial
Serial EValuation of multiplE Coronary Artery Diseases by an Optical Coherence Tomography; Assessment of the Changes of de Novo Lesions and Comparisons of Neointimal Coverage Between Xience Prime® Versus Cypher SelectTM Stents; SEVEN-Xience Study
Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.
All 14 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 14